Panpikoon Tanapong, Phattharaprueksa Wisanu, Treesit Tharintorn, Bua-Ngam Chinnarat, Pichitpichatkul Kaewpitcha, Sriprachyakul Apichaya
Department of Diagnostic and Therapeutic Radiology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, 270 Rama VI Rd. Phyathai, Ratchathewi, 10400, Bangkok, Thailand.
Thromb J. 2021 Dec 14;19(1):99. doi: 10.1186/s12959-021-00352-0.
To evaluate the anticoagulant treatment response in venous thrombi with different morphologies (size, shape, and echogenicity) by measuring the change in thrombus thickness.
This was a retrospective cohort study of 97 lower extremity DVT patients diagnosed by venous ultrasound between March 2014 and February 2018. The demographics, clinical risk factors, anticoagulant treatment, and ultrasound findings at the first diagnosis and 2-6 months after treatment were evaluated.
The anticoagulant treatment with LMWH followed by VKAs showed a significant decrease in the mean maximum difference in lower extremity DVT thrombus thickness compared with VKAs alone (P-value < 0.001). After adjustment by treatment, the thrombi found in dilated veins showed a significant decrease in the thickness of such thrombi compared with those found in small veins: 4 mm vs. 0 mm (Coef. = 3, 95% CI: 1.9, 4.1 and P-value < 0.001). Anechoic and hypoechoic thrombi showed a significant decrease in the thickness compared with hyperechoic thrombi: 5 mm vs. 0 mm (Coef. = 4, 95% CI: 3.25, 4.74 and P-value < 0.001) and 3 mm vs. 0 mm (Coef. = 2, 95% CI: 1.34, 42.66 and P-value < 0.001), respectively. Concentric thrombi showed a significant decrease in thickness compared with eccentric thrombi: 4 mm vs. 0 mm (Coef. = 2, 95% CI: 1.45, 2.55 and P-value < 0.001).
The anticoagulant treatment with LMWH followed by VKAs shows a significant decrease in lower extremity DVT thrombus thickness compared with VKAs alone. After adjustment by treatment, the morphologic finding of acute thrombi shows a significantly decreased thickness compared with the morphologic finding of chronic thrombi.
通过测量血栓厚度变化来评估不同形态(大小、形状和回声性)静脉血栓的抗凝治疗反应。
这是一项回顾性队列研究,研究对象为2014年3月至2018年2月期间经静脉超声诊断的97例下肢深静脉血栓形成(DVT)患者。评估了患者的人口统计学资料、临床危险因素、抗凝治疗以及首次诊断时和治疗后2 - 6个月的超声检查结果。
与单独使用维生素K拮抗剂(VKAs)相比,低分子肝素(LMWH)序贯VKAs的抗凝治疗使下肢DVT血栓厚度的平均最大差值显著降低(P值<0.001)。经治疗因素调整后,与小静脉中的血栓相比,扩张静脉中的血栓厚度显著降低:4毫米 vs. 0毫米(系数 = 3,95%置信区间:1.9, 4.1,P值<0.001)。无回声和低回声血栓的厚度与高回声血栓相比显著降低:分别为5毫米 vs. 0毫米(系数 = 4,95%置信区间:3.25, 4.74,P值<0.001)和3毫米 vs. 0毫米(系数 = 2,95%置信区间:1.34, 42.66,P值<0.001)。同心血栓的厚度与偏心血栓相比显著降低:4毫米 vs. 0毫米(系数 = 2,95%置信区间:1.45, 2.55,P值<0.001)。
与单独使用VKAs相比,LMWH序贯VKAs的抗凝治疗使下肢DVT血栓厚度显著降低。经治疗因素调整后,急性血栓的形态学表现与慢性血栓的形态学表现相比,厚度显著降低。